F.D.A. Rejects Closely Watched Lung Cancer Drug From China

2026-11-15 20:33 • ;Rebecca Robbins
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
Read More Here: https://www.nytimes.com/2026/11/15/business/fda-lung-cancer-drug-china.html